Open original FDA record ↗Recall record
- FDA identifier
- Z-0417-2007
- Company in FDA record
- Beckman Coulter Inc
- FDA classification date
- Feb 7, 2007
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 20, 2026
- Recall classification
- Unknown — no matched enforcement classification
Reason stated in the source
Low end imprecision affecting both S0 calibrators and patient samples which can lead to inaccurate low level patient results when using the Access Thyroglobulin Antibody assay.
Source facts
- Action
- A Product Corrective Action (PCA) letter was mailed on Oct 27, 2006 to all Thyroglobulin Antibody customers. They are informed that there has been an increase in customer feedback regarding low end imprecision affecting both S0 calibrators and patient samples, which can lead to inaccurate low level patient results when using the Access Thyroglobulin Antibody assay. The letter informs the customer that the firm recommends that they use an alternate method for testing TgAb. (Letter was sent by US mail). Customers are asked to complete and return the enclosed response form within 10 days.
- Initiated
- 2006-10-26
- Root cause
- Other
- Terminated
- 2012-04-30
- Distribution
- Nationwide and Canada
- Recall number
- Z-0417-2007
- Recall status
- Terminated
- CDRH record ID
- 49841
- FDA classified
- 2007-02-07
- Recall event number
- 37065